Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Head and Neck Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Ovarian Neoplasms 3 Nasopharyngeal Carcinoma 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Anus Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Select Advanced Solid Tumors 1 SCLC, Extensive Stage 1 SCLC 1 Retinoblastoma 1 Retinal Neoplasms 1 Recurrence 1 Radiation Therapy 1 Prostatic Neoplasms 1

Interventions

Cyclophosphamide 10 Magnetic Resonance Spectroscopy 8 Temozolomide 6 Biopsy 6 dinutuximab 5 X-Rays 5 Topotecan 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Irinotecan 5 Etoposide 3 Colony-Stimulating Factors 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 sargramostim 2 pembrolizumab 2 palbociclib 2 naxitamab 2 larotrectinib 2 ivosidenib 2 fludarabine phosphate 2 fludarabine 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Lenalidomide 2 Isotretinoin 2 Granulocyte-Macrophage Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neuroblastoma × Drug Therapy × Clear all

NCT05421897 2026-01-29

RAPID

Children's Hospital Los Angeles

Phase 1 Active not recruiting

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡